Guangxi LiuYao Group Co., Ltd
603368.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.15B
Close$
Share Statistics
| Market cap | $6.15 Billion |
|---|---|
| Enterprise Value | $10.43 Billion |
| Dividend Yield | $0.68 (4.39%) |
| Earnings per Share | $1.79 |
| Beta | 0.37 |
| Outstanding Shares | 397,211,355 |
Return
| Return on Equity | 8.24% |
|---|---|
| Return on Assets | 3.15% |
| Return on Invested Capital | 10.59% |
Valuation & Multiples
| P/E Ratio | 9 |
|---|---|
| PEG | -185.75 |
| Price to Sales | 0.29 |
| Price to Book Ratio | 0.78 |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | 10.28 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.74 |
| Debt to Equity | 0.98 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$5.15 B
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$5.15 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Guangxi LiuYao Group Co., Ltd
5,627 employees
CEO: Chaoyang Zhu Guangxi LiuYao Group Co., Ltd., a company established in 1981 and headquartered in Liuzhou, China, focuses on the wholesale and retail of pharmaceutical goods across the Chinese market. Furthermore, it operates as a subsidiary of Liuzhou Liangmianzhen Co., Ltd.